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Chromosomal barcoding as a 
tool for multiplexed phenotypic 
characterization of laboratory 
evolved lineages
Leonie Johanna Jahn1, Andreas Porse1, Christian Munck1,2, Daniel Simon1, Svetlana Volkova  1 
& Morten Otto Alexander Sommer  1
Adaptive laboratory evolution is an important tool to evolve organisms to increased tolerance towards 
different physical and chemical stress. It is applied to study the evolution of antibiotic resistance as well 
as genetic mechanisms underlying improvements in production strains. Adaptive evolution experiments 
can be automated in a high-throughput fashion. However, the characterization of the resulting lineages 
can become a time consuming task, when the performance of each lineage is evaluated individually. 
Here, we present a novel method for the markerless insertion of randomized genetic barcodes into 
the genome of Escherichia coli using a novel dual-auxotrophic selection approach. The barcoded E. coli 
library allows multiplexed phenotyping of evolved strains in pooled competition experiments. We use 
the barcoded library in an adaptive evolution experiment; evolving resistance towards three common 
antibiotics. Comparing this multiplexed phenotyping with conventional susceptibility testing and 
growth-rate measurements we can show a significant positive correlation between the two approaches. 
Use of barcoded bacterial strain libraries for individual adaptive evolution experiments drastically 
reduces the workload of characterizing the resulting phenotypes and enables prioritization of lineages 
for in-depth characterization. In addition, barcoded clones open up new ways to profile community 
dynamics or to track lineages in vivo or situ.
Lineage tracking is a valuable tool used to answer many fundamental biological questions regarding the evolu-
tionary forces and principles behind adaptation processes1. Tracking of lineages resulted in the identification of 
key parameters for evolutionary dynamics2, shed light on the deterministic character of evolution3, deepened our 
knowledge in dynamic genetic interactions4 and helped us to characterize genetic functions5–7 as well as specific 
mutations in more detail in direct competition experiments8 or complex environments such as the gut9–11.
Different methods have been utilized to track the population dynamics of co-existing lineages. The first stud-
ies applied light microscopy to track cells12,13. Later fluorescent tags were used in microscopy to follow specific 
phenotypes over time14,15, during development in vivo16–18, in cancer models17 or to trace individual lineages of 
cells in a population19,20. Fluorescent tags have also been used for evolution experiments2 and for allele tracking 
with qPCR8. More recently, genetic approaches have been used for lineage tracking. Whole genome sequenc-
ing enabled researchers to follow the evolution of individual MRSA strains in a human host during antibiotic 
treatment21, to characterize the colonialization of the infant gut10,11 or to perform multiplexed phenotyping of 
different gut microbiome species22. In addition, the insertion of genetic elements such as microsatellite regions23 
or genetic barcodes3 has broadened our understanding of evolutionary dynamics. While whole genome sequenc-
ing is needed to track unmodified bacterial strains in in situ, tracking genetically barcoded clones by amplicon 
sequencing provides a cheaper and faster alternative when the strains can be genetically manipulated.
Here, we present a novel method describing the markerless integration of genomic barcodes at a specific loca-
tion in the genome of E. coli without inserting selection markers or altering the genomic sequence except for the 
additional nucleotides of the barcode. We created a library composed of more than 400 clones carrying unique 
12-nucleotide barcodes, that is available upon request, and used a subset of these clones in an adaptive laboratory 
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evolution (ALE) experiment towards antibiotic resistance. Finally, we showed, as a proof of concept that the 
multiplexed phenotyping enabled through the barcoding scheme presented here, correlates well with traditional 
phenotyping methods based on individual clones and allows deeper insights into the population dynamics that 
would not be detected by traditional growth assays.
Results
Dual-auxotrophic selection allows for markerless insertion of genetic barcodes. To develop a 
tool for elucidating the dynamics of clonal populations we engineered a library of uniquely barcoded E. coli 
strains. As selection markers, especially those that confer antibiotic resistance, could potentially interfere with our 
interest of studying de novo antibiotic resistance mutations, we developed a protocol that allows the marker-free 
insertion of genetic barcodes into the genome of E. coli. Insertion of the unique barcodes occurred in a two-step 
process; first leuD of the leucine operon was knocked out with a chloramphenicol resistance gene resulting in 
a leucine auxotroph and chloramphenicol resistant clone. In the second step the leuD gene was reintroduced 
with a fragment containing a random 12-nucleotide barcode removing the chrolamphenicol marker and restor-
ing leucine autotrophy (Fig. 1). The fragment was created with a primer containing an overhang of 12 random 
nucleotides allowing us to introduce up to 412 unique barcodes in a single step. We then selected clones that were 
chloramphenicol sensitive and leucine autotroph. A region including the barcode and part of leuD was sequenced 
to confirm the correct insertion of the leuD gene and the specific sequence of each barcode. From the sequencing 
data we compiled a library composed of 445 clones each harboring a unique barcode at the same position in the 
genome (SI Table 1).
Evolution of antibiotic resistance using uniquely barcoded parallel evolving lineages. ALE 
experiments are commonly applied to study the evolution of antibiotic resistance24–29. To illustrate the potential 
of a library with unique barcodes that allow the tracking and comparison of evolving populations, a subset of the 
library was used in an antibiotic ALE experiment.
Figure 1. Cloning strategy for creating the barcoded library. leuD, part of the leucine operon and essential to 
produce leucine, was replaced with a chloramphenicol resistance gene through recombeneering51. Clones were 
screened for leucine auxotrophy and chloramphenicol resistance (CHL R). In a next step the replacement was 
reverted using the native leuD gene attached to a random 12-nucleotide long genetic barcode. Clones were 
selected when they were leucine autotroph and chloramphenicol sensitive (CHL S). Barcode integration was 
confirmed via Sanger sequencing. A library of 445 uniquely barcoded clones was compiled and cured from the 
recombeneering plasmid.
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We adapted 8 parallel lineages to 3 different antibiotics, the aminoglycoside amikacin (AMK), the tetracycline 
doxycycline (DOX) and the beta-lactam antibiotic cefepime (FEP) as well as to lysogenic broth (LB) medium as 
a control (Fig. 2A). The 3 drugs represent 3 major antibiotic drug classes with different mechanisms of action, 
including both bactericidal as well as bacteriostatic drugs. For the ALE experiment, we inoculated each replicate 
with a uniquely barcoded clone. Therefore, 32 different genetically barcoded lineages were required and randomly 
selected from the barcoded library. The ALE was carried out for 18 days and was started at sub-inhibitory antibiotic 
concentrations. The drug concentrations were increased by 25% at every daily transfer as previously described29. 
The IC90 of the wild type (WT) was reached on the 7th day of evolution. The IC90 is defined as the drug concentra-
tion at which the optical density (OD600) of the tested strain is 10% of the OD600 of the WT grown without exposure 
to the respective drug8. On the last day of the evolution experiment, lineages were exposed to drug concentrations 
exceeding the WT IC90 by at least 10-fold. Exact drug concentrations for each day and each drug can be found in 
SI Table 2. A single colony was isolated at the end of the evolution experiment for each replicate lineage (Fig. 2B).
Figure 2. Workflow of the adaptive laboratory evolution (ALE) and subsequent phenotyping. (A) ALE towards 
amikacin (AMK), cefepime (FEP) and doxycycline (DOX) resistance. Uniquely barcoded Escherichia coli K12 
clones were adapted to AMK, FEP, DOX and the media (LB) for 18 days in 8 replicates. Each replicate carried 
a unique chromosomal barcode. The populations were transferred every 22 hours with a 20-fold dilution to an 
increased drug concentration of 25%. The drug concentration at which the OD600 of the WT was 10% of the 
OD600 of the positive control before the evolution experiment was started (WT IC90) was reached on the 7th day of 
the evolution experiment. The drug concentration of the last day of the experiment was more than 10-fold higher 
than the WT IC90. (B) After the completion of the ALE each lineage was streaked on LB and a single colony was 
chosen for further experiments. (C) Competition experiment of evolved barcoded clones in different antibiotic 
concentrations. Outgrown cultures of all clones were mixed with equal volumes and used to inoculate media with 
five different drug concentrations for each antibiotic, as well as without antibiotic (in triplicates). Samples were 
taken after 2, 4 and 8 hours. (D) Traditional phenotyping methods such as growth kinetics in different antibiotic 
concentrations and resistance level determination in a drug gradient were performed for each clone.
www.nature.com/scientificreports/
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Traditional phenotyping methods reveal cross-resistance between DOX and FEP evolved lin-
eages. Traditionally the resistance level of a single clone is determined by measuring the minimal inhibitory 
concentration in microbroth dilutions. We measured the IC90 of all lineages towards the 3 antibiotics using 2-fold 
microbroth drug dilutions. All lineages evolved high-level resistance to the drug they were exposed to during the 
evolution experiment (Fig. 3). The IC90 values of the media adapted WT were comparable to the IC90 values of the 
ancestor WT, measured before the experiment started, as the average of the media adapted IC90 values were less 
than 2-fold different from the original IC90 values (SI Table 3). Yet, a variability among biological replicates was 
observed that might be accounted by media adaptations potentially altering the susceptibility profiles30. The most 
resistant clones for each drug were ~50 (AMK), ~60 (FEP) and ~30 (DOX) fold more resistant compared to the 
WT, while the least resistant clones were only 5-fold more resistant than the ancestor (Fig. 3). This highlights that 
adaptive evolution towards these drugs can follow a wide range of evolutionary trajectories.
Lineages that become resistant to one antibiotic often display either resistance or increased susceptibility to 
other antibiotics25,26,31. These phenotypes are referred to as collateral resistance and sensitivity, respectively. In 
this study, clones evolved to FEP displayed an elevated resistance towards DOX and vice versa. DOX and FEP 
evolved lineages were on average slightly more susceptible towards AMK than the media adapted WT (Fig. 3). 
Mutations increasing drug efflux through AcrAB are commonly found in antibiotic resistant bacteria8,26,32. While 
increased efflux confers resistance towards many different antibiotics, it is not effective against aminoglycosides26. 
An interaction between the membrane potential, crucial for the uptake of aminoglycosides, and AcrAB mediated 
efflux has previously been documented to explain the collateral sensitivity of aminoglycoside resistant strains 
towards other antibiotics such as DOX and FEB26. This well explained mechanism of collateral sensitivity was also 
observed in this study between cells adapted to AMK tested in FEP. Yet, it does not explain the observed collat-
eral sensitivity between DOX and FEP evolved lineages towards AMK. We speculate that cells adapted to a high 
AcrAB mediated efflux are also adapted to sustain a high membrane potential to fuel the high efflux rate. This in 
turn could result in a higher uptake of aminoglycosides, explaining the slightly increased susceptibility of DOX 
and FEP evolved lineages towards AMK.
Growth-rate measurements are another standard experiment used as a proxy for the fitness in the character-
ization of mutants resulting from ALE experiments33–35. We assessed the growth rate of the evolved clones in a 
sub-inhibitory concentration as well as in 2, 4 and 8 fold of the WT IC90 drug concentrations for all three drugs 
in 2 technical replicates (Fig. 4A–C). The doubling time was normalized with the doubling time of the ancestor 
(WT) growing in LB medium without antibiotics (Fig. 4A–C, SI Table 4). The medium adapted lineages had a 
similar doubling time compared to the ancestral WT (Fig. 4A–C). The drug-evolved clones had slower growth 
rates compared to the media evolved lineages (SI Tables 4 and 5, Mann-Whitney-U-test, p < 2.2e−16). All lineages 
were capable of growing in the sub-inhibitory drug concentrations of all 3 drugs; indicating the absence of strong 
evolved collateral sensitivity. As a general trend it can be noticed that the doubling time increases with the anti-
biotic concentration; also for the clones that were adapted to the respective drug. We observed some exceptional 
clones (biological replicates 1 and 6 of AMK evolved lineages, biological replicate 2 of FEP evolved lineages and 
biological replicate 6 of DOX evolved lineages, SI Table 4) with a stable doubling time independent of the drug 
concentration for all 3 drugs. For AMK and DOX adapted lineages those clones were among the most resistant 
Figure 3. Antibiotic susceptibility of evolved isolates. Inhibitory drug concentrations (IC90) of (A) amikacin, 
(B) cefepime and (C) doxycycline after the adaptive laboratory evolution (ALE) experiment. The IC90 was 
measured for all 8 biological replicates after the adaptive evolution experiment for all 3 drugs. Clones adapted to 
amikacin (AMK), cefepime (FEP), doxycycline (DOX) and medium (LB) are displayed in yellow, blue, purple 
and green, respectively.
www.nature.com/scientificreports/
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ones while no correlation between the resistance level and the growth kinetics could be established for FEP 
evolved clones. In the 2-fold WT IC90 drug concentrations some media adapted lineages are unexpectedly able to 
grow. However, often only one of the technical replicates was able to grow, lag phase was prolonged and the final 
OD levels were reduced compared to growth in sub-inhibitory concentrations (Fig. 4D–F). These growth patterns 
could be explained by genotypic differences in the media adapted lineages that could potentially alter their sus-
ceptibility patterns30 or by spontaneous mutations arising during the growth rate measurements. Lineages evolved 
to DOX and FEP displayed a cross-resistance phenotype as also indicated by the IC90 measurements.
Barcoding allows for multiplex phenotyping of evolved strains. By pooling the clones for multi-
plexed phenotyping based on the barcodes it is possible to reduce the workload needed for the characterization 
of single clones; especially, when many different conditions are analyzed. We hypothesized that outcomes of the 
multiplexed analysis would be comparable to our data obtained for each clone tested individually. To test this 
hypothesis, outgrown overnight cultures of all clones were mixed in equal volumes. A sample of this mixture was 
frozen as time point 0. Of the remaining mixture, 5 ml of media either without antibiotic, with sub-inhibitory 
drug concentrations, or 3 different drug concentrations above the WT IC90 were inoculated in triplicates for each 
antibiotic (Fig. 1C). Samples were taken after 2, 4 and 8 hours.
The barcode was amplified and deep sequenced for the whole population subjected to each condition, repli-
cate and time point, and the barcode frequencies were normalized to time point 0. The average of the replicates 
Figure 4. Growth properties of evolved clones. Doubling time of evolved lineages in different concentrations 
of (A) amikacin, (B) cefepime and (C) doxycycline. The doubling time of the evolved lineages was measured 
without antibiotic (0 × WT IC90), in sub-inhibitory drug concentrations (0.25 × WT IC90) and in 2, 4 and 8 fold 
of the WT IC90. The doubling time was normalized to the ancestor WT grown in antibiotic free LB medium. 
Clones adapted to AMK, FEP, DOX and LB are displayed in yellow, blue, purple and green, respectively. The 
intensity of the color increases with the resistance level towards the drug they were evolved to. Growth curves of 
media adapted clones in (D) amikacin, (E) cefepime and (F) doxycycline. The growth curves of all 8 biological 
and 2 technical replicates of the media adapted clones reveal a huge difference in the growth phenotype in sub-
inhibitory drug concentrations (black lines) and 2-fold WT IC90 drug concentrations (grey lines).
www.nature.com/scientificreports/
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was calculated. In the antibiotic free medium, the LB medium adapted WT appears to be dominating. However, 
its fitness advantage was not pronounced enough to outcompete the other clones within an 8-hour competi-
tion experiment (Fig. 5). The fitness benefit of the WT is only detected in conditions without selection. Under 
selection clones adapted to the respective drug are clearly favored over time (Fig. 5). The time needed until the 
drug-adapted lineages dominate the population varies for each drug. In AMK AMK-evolved clones take over the 
population already within the first 2 hours of growth while 8 hours are not enough for the FEP-adapted clones to 
fixate despite FEP treatment. The frequencies of the biological replicates adapted to the same drug varied when 
exposed to different drug concentrations. The most resistant clone for DOX is dominating the population after 
8 hours only when the population was exposed to 4 and 8 fold WT IC90 drug concentrations but not at 2-fold 
(Fig. 5). All lineages adapted to AMK and FEP were more resistant than 8 fold of the WT IC90 of the respective 
drug. Drug conditions below the resistance level seem not necessarily to select for the mutant with the highest 
IC90 value and other fitness aspects appear more influential under these conditions.
Interestingly, we observed, in the populations exposed to inhibitory drug concentrations of FEP, that DOX 
adapted lineages are outcompeted more than AMK adapted lineages. This result stands in contrast to the individ-
ual growth kinetics of the clones that did not allow AMK adapted clones to grow under these conditions while 
DOX adapted lineages were able to grow also in higher FEP concentrations (Figs 4A–C and 5). Consistent with 
Figure 5. Relative barcode frequencies for each lineage over time in different concentrations of amikacin 
(AMK), cefepime (FEP) and doxycycline (DOX). Each column represents the different conditions: lineages 
grown in the media without drug (media), media containing sub-inhibitory drug concentrations (0.25 WT 
IC90) or three different concentrations above the WT IC90 (2×, 4× and 8× WT IC90). The three rows represent 
the three different drugs. Each plot displays the relative barcode abundance of each lineage over time. Clones 
adapted to AMK, FEP, DOX and media are displayed in yellow, blue, purple and green, respectively. The 
intensity of the color increases with the resistance level of each clone towards the drug they were evolved to.
www.nature.com/scientificreports/
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the ability of FEP adapted lineages in the single growth kinetic measurements, FEP adapted lineages are also able 
to grow in low inhibitory concentrations of DOX in the pooled populations (Fig. 5).
In summary the IC90 determines largely weather a lineage is able to grow under a specific drug regime. 
However, other factors influencing the fitness, e.g. the costs of adaptations as well as the interaction with other 
lineages, decide about the degree of growth under the respective condition.
The results from traditional and multiplexed phenotyping methods are positively correlated. 
Finally, we tested our hypothesis that pooled and individual clone characterization results in similar outcomes 
by correlating the fitness of the clones based on the pooled and individual experiments. In the linear regression 
model we used the fitness derived from the single clone measurements as the predictor and the fitness calculated 
from the barcode frequencies as a response variable. We find a significant (P < 0.05, Pearson’s product-moment 
correlation), positive correlation of the fitness in all conditions after 8 hours of growth (Fig. 6). However, the 
variability is fairly high and the R2 varies from 0.16–0.85 dependent on the drug and condition. The variability 
in the linear regression models for FEP exposed lineages is especially high. As described before we also observed 
a discrepancy in the phenotypes of the pooled analysis and the single clone measurements for DOX and AMK 
adapted lineages, which might account for the high variance. The variability would likely decrease by prolonging 
the competition experiment and therefore allowing the fittest clones more time to outcompete the other lineages.
Due to the high variability in the correlation between growth rates and competition outcomes, a second eval-
uation of the multiplexed phenotyping was performed. We ranked the fitness of each clone for each drug and 
Figure 6. Significant positive correlation of the fitness calculated based on individual and pooled phenotyping. 
The different columns represent the different conditions: lineages grown in the media, sub-inhibitory drug 
concentrations or three different concentrations above the WT IC90. The three rows represent the three different 
drugs. Each plot displays relative fitness calculated from the competition experiment versus the relative fitness 
derived from individual growth measurments. The coefficient R2 and the p-value of a Pearson’s product-
moment correlation are provided for each linear regression model (*P < 0.05, **P < 0.001). Clones adapted to 
amikacin (AMK), cefepime (FEP), doxycycline (DOX) and media are displayed in yellow, blue, purple and green, 
respectively. The intensity of the color increases with the resistance level towards the drug they were evolved to.
www.nature.com/scientificreports/
8Scientific REPORtS |  (2018) 8:6961  | DOI:10.1038/s41598-018-25201-5
condition from both multiplexed as well as individual phenotyping (SI Table 6). Under conditions with selection 
(2×, 4× and 8× WT IC90) the best performing clone obtained from the individual growth measurements was 
among the 5 best performing clones of the competition experiment in the same drug condition. Consequently, 
picking the best 5 clones for in depth characterization will likely include similar mutants regardless of the fitness 
assay used.
In conclusion, multiplexed phenotyping of a pooled set of clones correlates with traditional techniques to 
characterize mutants after ALE experiments and allows identifying the best performing clones under selecting 
conditions. The barcoded library, created for this study, is consequently a valuable resource for high-throughput 
ALE experiments as it reduces the workload of subsequent characterization of mutants drastically.
Discussion
Genetically barcoded strains are highly useful to study the population dynamics, also those that result from 
random processes e.g. population bottlenecks and genetic drift that are not driven by mutant selection, as well as 
evolutionary processes of heterogenic populations. In addition, barcoded clones can be used to multiplex phe-
notyping of a larger number of similar strains, e.g. those resulting from ALE experiments. Different strategies for 
genetic barcoding exist. Yet, to our knowledge all of them depend on the insertion of selection markers or other 
modifications of the genome1. Here, we present a novel approach for inserting genetic barcodes in the genome 
of Escherichia coli without any additional modifications. An unaltered genetic background can be important for 
example when different antibiotic resistant strains or clones shell be compared in their response to various antibi-
otics. Moreover, if barcoded clones are used for production strain improvements for example by ALE experiments 
or transposon mutagenesis and subsequent multiplexed phenotyping, an unaltered genetic background is desired 
as many production strains already carry genetic alterations and additional selection markers could limit the 
number of available markers. Additionally, selection markers might burden the cell, which could result in reduced 
growth rates. Therefore, a strain with as little genetic changes as possible is a desired starting material. To achieve 
the markerless insertion of genetic barcodes we used leuD as selection marker. Even though other selection sys-
tems using sacB, galK or thyA are well established they have a narrow compatibility with high escape rates36, 
which we did not observe for the native metabolic leuD gene. Auxotrophic selection markers can be established 
in every organism and belong to the standard tools for genome editing in yeast37,38, highlighting their potential 
role in genetic engineering of E. coli or other microbes.
Multiplexed phenotyping reduces the workload by screening for the fittest mutant under different conditions. 
While genetic barcodes might not be necessary when genetically distant lineages are used22, lineages resulting 
from ALE experiments might differ only in a few nucleotide polymorphisms29, wherefore genetic barcodes are 
required to distinguish clones from one another. We could show that multiplexed phenotyping results correlate 
with traditional phenotyping methods based on individual measurements. Small discrepancies were observed 
for clones adapted to AMK and DOX exposed to FEP. It should be noted that a shortcoming of the correlation 
analysis is that the growth rate measurements and pooled competition experiments characterize different aspects 
of bacterial fitness. While the doubling time is a widely accepted proxy for bacterial fitness38,39 it is calculated by 
using only a fraction (steepest part of the growth curve) of the whole growth curve that is taken into account in 
the competition experiment. Different growth dynamics, especially for strains subjected to antibiotic pressure, 
including different durations and behaviors of lag, log and stationary phases (Fig. 4 D–F) and interactions with 
other strains influence the outcome and resolution of competition experiments and might be especially important 
for physiologically challenged mutants. In fact, we observed altered growth dynamics for some mutants and con-
ditions, especially under exposure to FEP suggesting that growth rate measurements might be a better proxy for 
fitness under stress free conditions or for mutants that are not physically challenged. Additionally, the presence 
of other lineages can influence the performance of each clone in a given environment. By pooling all lineages 
the conditions are less controlled compared to individual growth kinetics, which might be attributed to nutrient 
availability, the antibiotic exposure and the overall composition of the media changing with metabolites produced 
from the other cells or through cellular material from lysed cells. Metabolic shifts can result in different tolerance 
levels for antibiotics40,41, suggesting that the production of metabolites by a subpopulation might influence the 
metabolism of susceptible clones increasing or decreasing their tolerance towards a certain antibiotic41. For exam-
ple, it has been found that resistant lineages can produce the compound indole that might increase the tolerance 
of susceptible clones in the population42. Those complex interaction dynamics in bacterial populations are more 
likely to be detected in pooled phenotyping setups and might more accurately reflect the fitness of bacteria in 
their natural habitats compared to measurements performed on individual clones.
Multiplexed phenotyping may not completely substitute traditional phenotyping methods. Yet, it can reduce 
the workload and help to identify promising lineages for in-depth characterization. In addition, it opens ways to 
study population dynamics, to detect cross-resistance and collateral sensitivity and to identify the fittest mutant 
in various conditions including challenging environments like urine, wastewater or in vivo models. Furthermore, 
clones adapted to the same condition can be compared in competition experiments, which can help to foster our 
understanding of the relation between genotype and phenotype.
In conclusion adaptive evolution using barcoded strains harbors a big potential in reducing workload of char-
acterization of evolved strains and opens up the opportunity for a more complex and detailed analysis of the 
population dynamics of co-existing lineages.
Materials and Methods
Creation of barcoded library. The first step towards the integration of 12-nucleotide long genetic bar-
codes in Escherichia coli was to amplify the chloramphenicol resistance gene from a pZ cloning vector43 with 
the following primers: KO_leuD_F: AGGTTAAAGACGTTTGATGACGT-GGACGATAGCGGAAAGCCCG
GTCATTTAGTGCTTGGATTCTCACC and KO_leuD_R: TGTG-ACCGGACATTTCGCCGACATTCGCAA
www.nature.com/scientificreports/
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CATTAAATAAGGAGCACACCCTCTGGTAAGGTTGGG, flanking the beginning of the leuD gene and the 
area downstream of the gene. The PCR product was purified with the NucleoSpin Gel and PCR Clean-up kit by 
Machery-Nagel according to the manufacturers instructions and used for electroporation in MG1655 carrying 
the pSim6 plasmid44 allowing the chloramphenicol resistance gene to replace leuD through recombeneering. 
Cells were recovered in lysogeny broth (LB) overnight and plated on LB agar containing chloramphenicol (30 μg/
ml) the next day. Colonies were picked and streaked on LB, LB containing ampicillin (100 μg/ml), LB contain-
ing chloramphenicol and on Synthetic Complete media (SC) lacking leucine. One clone that grew on all plates 
except the SC plate lacking leucine, was used to inoculate 5 ml LB containing ampicillin and chlorampheni-
col. It was used for recombination with another purified PCR product created with primers: Re_tag_leuD_F: 
GTTATTTCTGTTGTCGCA-TTATTTTTAACCGCAAAGGTTAAAGACGTTTGnnnnnnnnnnnnATGACGT
GGACGATAGCGG and Re_leuD_R: TGAACAACGACCGTCTGAATCC using MG1655 WT DNA as a tem-
plate. The forward primer is carrying the 12-nucleotide long random barcode. After recombination, cells were 
recovered overnight and plated on LB containing chloramphenicol. More than 1000 colonies were picked and 
streaked for isolated colonies on LB containing chloramphenicol as well as on SC lacking leucine. Isolated col-
onies that were sensitive to chloramphenicol and leucine autotrophs were picked and used to inoculate 96-well 
microtiter plates containing 150 μl of LB. 1 μl of the overnight culture was used for a colony PCR amplifying the 
barcoded area with the following primers: Re_leuD_F: GGATTTAATGCCTGGAAGAGC and Re_leuD_R. The 
PCR products were purified using the ZR-96-well DNA Clean-up kit by Zymo Research according to the manu-
facturers instructions. The purified products were used for Sanger sequencing using the Mix2Seq kit by Eurofins 
Genomics according the manufacturers instructions including Re_leuD_F as primer and the Sanger sequencing 
services by BaseClear. Clones that contained the leuD gene as well as an unique barcode were transferred to a 
new 96-well plate containing LB and the position was noted together with the barcode sequence. The clones were 
frozen in 25% glycerol stocks at −80 °C. Subsequently; these clones were grown at 42 °C to cure them from the 
pSim6 plasmid44. They were streaked on LB agar containing ampicillin and the same toothpick was used to inoc-
ulate a well in a 96-well plate. This was repeated until no colonies could be identified on the LB agar containing 
ampicillin. The final 96-well plate containing the cured clones were replicated into LB containing ampicillin using 
a 96-well pin-replicator and no growth was detected. The final barcoded library compasses 445 clones each with 
a unique barcode. A list of all barcodes can be found in SI Table 1. The cured strains were frozen in 25% glycerol 
stocks at −80 °C.
Adaptive laboratory evolution with barcoded strains. A subset of the barcoded library, 32 clones, 
were used for an ALE experiment. The clones were exposed to either AMK, FEP, DOX or LB in 8 biological repli-
cates. Another 8 wells contained LB media but were not inoculated to serve as a negative control. All negative con-
trol wells stayed uncontaminated throughout the experiment. The antibiotic exposure started at sub-inhibitory 
drug concentrations and was raised every day by 25%29 reaching the WT IC90 on the 7th day of evolution and 
ending after 18 days with a >10 fold higher drug concentration than the WT IC90. The exact drug concentrations 
for each day of the experiment can be found in SI Table 2. The experiment was performed in a volume of 1 ml in 
96-deep well plates by Almeco. All plates were prepared with fresh drug stocks prior to the experiment and kept 
at −20 °C. Every 22 hours, the optical density was measured at a wavelength of 600 nm (OD600) in an ELx808 
Absorbance reader (BioTek), 50 μl of the cultures were frozen at −80 C in 25% glycerol and 50 μl were used to 
inoculate a fresh plate with a higher drug concentration. The new plate was defrosted on the day of usage and 
preheated to 37 °C. The inoculated plates were incubated at 37 °C and 900 r.p.m. Each lineage was streaked on LB 
agar after completion of the ALE and an isolated colony was obtained for further experiments.
IC90 determination. Each isolated colony was grown in LB overnight and a 96-well pin-replicator (Almeco) 
was used to inoculate the broth microdilutions in technical replicates. A 2-fold drug gradient was used for each 
antibiotic. Growth was normalized with the average blank values from the negative controls and the average 
growth in media without antibiotic as described before8,29. Dose response curves were fitted to the data using 
R45,46 and the concentration at which the OD600 was 10% of the OD600 of the positive control, was determined8,29,47. 
All IC90 values are presented in SI Table 7 along with MIC values, determined according to standard protocols48.
Growth rate measurements. 96-well microtiter plates containing 200 μl LB and different antibiotic con-
centrations (SI Table 8) were inoculated with a 96-well pin-replicator (Almeco) with cells in exponential growth 
phase. On each plate, 4 wells were reserved to the ancestor WT growing in LB and at least 4 wells served as nega-
tive controls. The OD600 was measured every 5 min for 20 hours. The plates were kept at 37 °C and 650 r.p.m. The 
data was analyzed with R46,49, calculating the doubling time based on the steepest part of the growth curve29. The 
doubling time was normalized to the doubling time of the ancestor WT in LB.
Fitness calculation based on growth kinetics. The fitness was calculated based on the doubling time. 
The average doubling time of the ancestor WTs growing in LB was divided by the doubling time of each lineage 
as described before4. The average and standard derivation of the replicates was calculated in RStudio (0.99.467).
Competition experiment. For multiplexed phenotyping all clones were grown in LB overnight and 
mixed in equal volumes. An aliquot of this starting mixture was frozen as time point 0. 50 μl of the mixture were 
used for inoculation of every triplicate of 4 different (one sub-inhibitory and three inhibitory) drug concen-
trations for each antibiotic in a total volume of 5 ml. The exact drug concentrations are provided in SI Table 8. 
The tubes were incubated at 37 °C and 1200 r.p.m. After 2, 4 and 8 hours 500 μl of the cultures were sampled 
and frozen at −20 °C. Depended on the drug condition and time point varying amounts of the samples (0.5–
250 μl) were used for further analysis. 0.5 μl of the samples taken from 0 and 8 hours were mixed with 12.5 μl 
water. For the other time points varying amounts were spun down so that a tiny pellet was visible in the tube. 
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The pellet was resuspended in 13 μl of autoclaved miliQ water. All samples were incubated at 99 °C for 7 min-
utes. A 15-cycle PCR was performed directly on the cells using the following primers 40-fold diluted: Fwd_
Primer: TCGTCGGCAGCGTCAGAGTGTATAAGAGACACAATGACCGGGCTTT-CCGC and Rev_Primer: 
GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGGATGCTATGG-TTTCAGG with homology to the 
NEBNext Multiplex Oligos for Illumina (Index primer sets A and C) (New England BioLabs). The PCR product 
was directly used for indexing PCR with 20 cycles using the NEBNext Multiplex Oligos for Illumina (Index 
primer sets A and C) (New England BioLabs) according to the manufacturers instructions. The PCR products 
were purified using the ZR-96-well DNA Clean-up kit by Zymo Research according to the manufacturers instruc-
tions. The DNA quantity was measured with the Qubit dsDNA HS Assay kit (Thermo Fisher Scientific) and 
samples were pooled in equal amounts of DNA for sequencing on an Illumina MiSeq with 150 bp paired ends.
Determination of the barcode frequencies. The frequencies of the different barcode in each condition 
were determined in CLC Genomics workbench (Qiagen) and blasting them against a database composed of the 
barcode sequences (SI Table 9). A p-value of 0.0001 was used as a cut off for the homology to ensure only perfect 
matches. A table with the number of hits for each barcode was obtained for each condition and time point. The 
table was extracted and R was used for further analysis. The counts were normalized to time point 0 and the 
relative abundance of each barcode was calculated for each condition. Few barcodes from the media adapted 
lineages and well as DOX adapted lineages could not be detected and were therefore excluded from the analysis. 
The relative barcode frequencies were plotted over time for each condition using R.
Fitness calculation based on barcode frequencies. The fitness of the strains was calculated based on 
the barcode frequencies from the competition experiment and the calculations were performed according to an 
adjusted procedure by Wetmore et al.6. The binary logarithm of the number of reads of a specific barcode at time 
point 0 was subtracted from the number of reads of the same barcode after 8 hours of growth in a specific condi-
tion. The average and standard derivation of the triplicates was calculated.
Statistical tests. The fitness calculated based on the individual growth measurements was used as a pre-
dictor variable and the fitness based on the competition experiment served as the response variable for a lin-
ear regression model built with ggplot2 in R. The Pearson’s correlation coefficient of determination R2 and the 
p-value were calculated and added to the plots using two functions (stat_poly_eq() and stat_fit_glance()) from 
the ggpmisc package50. Actual p-values can be found in SI Table 10. Following significance levels were used for 
the p-value in Fig. 5: *for p < 0.05, **for p < 0.001. Moreover, the p-values were validated with an additional 
spearman’s correlation (using R statsv3.4.449) that is more robust to non-parametric data and can be found in SI 
Table 10.
Data availability. The datasets generated during and analyzed during the current study are available from 
the corresponding author on reasonable request. Barcoded E. coli strains can be requested from the correspond-
ing author.
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